E-LIB Suche - Ergebnisse für: Cömert, Melda

1

Eltrombopag treatment in thrombocytopenia following hematop..:

Kilic Gunes, Ebru ; Yigit Kaya, Sureyya ; Yaman, Fatih...
Leukemia Research. 140 (2024) - p. 107484 , 2024

2

MDS-143 Characteristics and Outcomes of Myelodysplastic Syn..:

Açar, İbrahim Halil ; Atalay, Figen ; Demirsoy, Esra Terzi...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S354 , 2023

Link: https://doi.org/10.1016/..

3

GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RE..:

DOGU, Mehmet Hilmi ; TEKGUNDUZ, Ali Irfan Emre ; DEVECI, Burak...
Mediterranean Journal of Hematology and Infectious Diseases. 15 (2023) 1 - p. e2023031 , 2023

Link: https://doi.org/10.4084/..

4

POSTER: MDS-143 Characteristics and Outcomes of Myelodyspla..:

Açar, İbrahim Halil ; Atalay, Figen ; Demirsoy, Esra Terzi...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S180 , 2023

Link: https://doi.org/10.1016/..

5

PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULT:

Dogu, Mehmet Hilmi ; Tekgunduz, Ali Irfan Emre ; Deveci, Burak...
HemaSphere. 7 (2023) S3 - p. e4210211 , 2023

Link: https://doi.org/10.1097/..

6

AML-179: Seasonal Association of Acute Promyelocytic Leukem..:

Cömert, Melda ; Güneş, Ebru Kılıç ; Yıldırım, Murat...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S287-S288 , 2021

Link: https://doi.org/10.1016/..

7

Poster: MM-066: Primary Plasma Cell Leukemia: A Rare Entity..:

Cömert, Melda ; Yıldırım, Murat ; Sayın, Selim...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S254 , 2021

Link: https://doi.org/10.1016/..

8

Poster: AML-184: Administration of Cyclophosphamide for GVH..:

Sayın, Selim ; Yıldırım, Murat ; Cömert, Melda...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S213 , 2021

Link: https://doi.org/10.1016/..

9

Poster: AML-183: Cyclophosphamide-Based GVHD Prophylaxis Af..:

Yıldırım, Murat ; Sayın, Selim ; Cömert, Melda...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S212 , 2021

Link: https://doi.org/10.1016/..

10

AML-183: Cyclophosphamide-Based GVHD Prophylaxis After 9/10..:

Yıldırım, Murat ; Sayın, Selim ; Cömert, Melda...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S288 , 2021

Link: https://doi.org/10.1016/..

11

VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TR..:

Cömert, Melda ; Bulduk, Tuba ; Uğur, Bilge...
Hematology, Transfusion and Cell Therapy. 43 (2021) - p. S33-S34 , 2021

Link: https://doi.org/10.1016/..

12

AML-184: Administration of Cyclophosphamide for GVHD Prophy..:

Sayın, Selim ; Yıldırım, Murat ; Cömert, Melda...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S288-S289 , 2021

Link: https://doi.org/10.1016/..

13

Poster: AML-179: Seasonal Association of Acute Promyelocyti..:

Cömert, Melda ; GüneŞ, Ebru Kılıç ; Yıldırım, Murat...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S212 , 2021

Link: https://doi.org/10.1016/..

14

MM-066: Primary Plasma Cell Leukemia: A Rare Entity with Fo..:

Cömert, Melda ; Yıldırım, Murat ; Sayın, Selim...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S418 , 2021

Link: https://doi.org/10.1016/..

15

A multi-centric study on the efficacy of eltrombopag in man..:

Cekdemir, Demet ; Guvenc, Serkan ; Ozdemirkiran, Fusun...
Turkish Journal of Hematology. , 2019

Link: https://doi.org/10.4274/..